unknown
Stage
2
Investors
About
Vactech develops preventive vaccines and diagnostics targeting type 1 diabetes, celiac disease, and enterovirus-related conditions, focusing on innovative biotechnology solutions to reduce immune-mediated diseases globally.
Explore Vactech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.